SCHEMBL8330465

SCHEMBL8330465

OCc1ccc(-c2n[nH]c3cc(F)cc(Cc4cccc(Cl)c4)c23)o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.39
MAP2K4 P45985 2/20 0.36
SOS1 Q07889 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
MAPK1 P28482 3/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
GMNN O75496 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
NFKB1 P19838 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8328669 0.88 MAP2K4 (0.43) PDE5AMAP2K4SOS1HCAR2MAPK1
SCHEMBL8328753 0.82 PDE5A (0.37) PDE5AMAP2K4MAPK1ALDH1A1LMNA
SCHEMBL8330242 0.77 MAP2K4 (0.39) PDE5AMAP2K4HCAR2MAPK1ALDH1A1
SCHEMBL163795 0.76 HIF1A (0.44) PDE5AMAP2K4MAPK1ALDH1A1LMNA
SCHEMBL8329920 0.73 PDE5A (0.44) PDE5AMAP2K4SMN1; SMN2HIF1AEPAS1
SCHEMBL8332364 0.72 PDE5A (0.41) PDE5AMAP2K4MAPK1ALDH1A1LMNA
SCHEMBL8470062 0.68 CYP1A2 (0.36) PDE5AMAP2K4MAPK1ALDH1A1LMNA
SCHEMBL8327929 0.66 PDE5A (0.37) PDE5AMAP2K4MAPK1ALDH1A1LMNA
SCHEMBL8471597 0.65 MAP2K1 (0.41) PDE5AMAP2K4MAPK1ALDH1A1LMNA
SCHEMBL6224032 0.65 PDE5A (0.83) PDE5AMAPK1ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932403-A1 USE OF CONDENSATED (HETARYL-SUBSTITUTED) 1-BENZAL-3-PYRAZOL DERIVATES FOR TREATING SPECIAL DISEASES OF THE CARDIOVASCULAR AND THE CENTRAL NERVOUS SYSTEMS BAYER AG (DE) 1999-08-04 EP claimed
WO-1998016223-A1 USE OF CONDENSATED (HETARYL-SUBSTITUTED) 1-BENZAL-3-PYRAZOL DERIVATES FOR TREATING SPECIAL DISEASES OF THE CARDIOVASCULAR AND THE CENTRAL NERVOUS SYSTEMS BAYER AKTIENGESELLSCHAFT (DE) 1998-04-23 WO claimed